NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#3)

Company

CRESCENT BIOPHARMA, INC.

Filed

February 29, 2024

Accession Number

0001072613-24-000287